Overall, we identify PLIN1 as a potential biomarker for multiple human cancer types, including breast cancer, low-grade glioma, hepatocellular carcinoma and sarcoma and highlight the prognostic value of PLIN1 mRNA levels in breast cancer outcomes. This evidence concerns the gene PLIN1 and breast carcinoma.